Genome sequence of OXA-23 producing Acinetobacter baumannii IHIT7853, a carbapenem-resistant strain from a cat belonging to international clone IC1
- 965 Downloads
Multidrug resistance in Acinetobacter baumannii has dramatically increased in recent years worldwide. Thus, last-line antibiotics like carbapenems are increasingly being used which in turn further augments selection pressure for resistant strains. Resistance to carbapenems in A. baumannii is frequently mediated by carbapenemases, particularly OXA-23 and OXA-58. Carbapenemase-producing bacteria are mainly described in human patients and the intestinal tract represents a common source for such pathogens. In this study, we sequenced and analyzed the genome of A. baumannii IHIT7853, a carbapenem-resistant, OXA-23 producing strain isolated from cystitis in a cat in 2000 in Germany.
Phylogenetic analysis revealed that IHIT7853 belonged to the globally distributed international clone IC1 and MLST type ST1/ST231 (Pasteur/Oxford MLST scheme). A phylogenetic tree based on the maximum common genome of 18 A. baumannii isolates placed IHIT7853 close to human clinical isolates, such as the multidrug-resistant (MDR) outbreak strain AYE that was isolated from a patient with pneumonia and cystitis in 2001 in France. The OXA-23 plasmid sequence could be determined as 53,995 bp in size, possessing resistance genes strA and strB in addition to bla OXA-23.
The analysis of the genome of IHIT7853 reveals that companion animals carry MDR A. baumannii that resemble relevant clonal lineages involved in severe infections in humans. As urinary tract infections are often caused by bacteria that reside in the intestinal tract, future studies should unveil, if the animal gut serves as a source for MDR A. baumannii.
KeywordsOXA-23 Acinetobacter Animal Carbapenemase
clusters of orthologous groups of proteins
clustered regularly interspaced short palindromic repeats
Acinetobacter baumannii is widely recognized as a nosocomial pathogen that is characterized by its intrinsic and acquired antimicrobial resistance. Of particular concern in hospital settings is the development of multidrug-resistant (MDR) and particularly of carbapenem-resistant strains, which have increased markedly in recent years . The intestinal microbiota forms a major reservoir of A. baumannii and various infections, including bacteraemia, cystitis and wound infections can occur once the bacteria translocate across the intestinal barrier or reach the patient’s skin as a consequence of faecal shedding [2, 3]. The finding of identical strains in the blood and gastrointestinal tract of patients with A. baumannii bloodstream infections strengthens the role of the gut as an important source of the pathogen .
Carbapenem resistance in A. baumannii is most frequently mediated through intrinsic (OXA-51-like) or acquired (e.g. OXA-23, OXA-58) carbapenem-hydrolyzing class D β-lactamases (CHDLs) that confer resistance once they are overexpressed . OXA-23-producing A. baumannii contribute to hospital-outbreaks worldwide and have recently tended to replace OXA-58-producing strains in some countries [1, 5, 6, 7, 8]. In Germany, the first outbreak of A. baumannii carrying the carbapenemase OXA-23 was observed in 2006 and nowadays it accounts for about 80 % of MDR A. baumannii in Germany [7, 9]. Until recently, carbapenem-resistant A. baumannii have been mainly described in human patients. However, previous studies have identified this species as an emerging pathogen particularly in hospitalized companion animals and horses [9, 10, 11]. Here, we report the genome sequence of the carbapenem-resistant A. baumannii strain IHIT7853 that was isolated from the urine of a hospitalized cat with cystitis.
Bacteria, DNA isolation, genetic relatedness and antimicrobial susceptibility testing
Acinetobacter baumannii strain IHIT7853 was isolated from the urine of a cat admitted to a veterinary clinic in November 2000. For genomic DNA extraction late log-phase cells were harvested and lysed with EDTA, lysozyme, and detergent treatment, followed by proteinase K and RNase digestion using the DNeasy Blood & Tissue Kit (Qiagen, Germany) according to the manufacturer´s recommendation. Genomic DNA yield, purity, and concentration was evaluated using 0.7 % agarose gel electrophoresis with λ-Hind III DNA marker (Thermo Fisher Scientific, USA). The genomic DNA was stored at −20 °C until use. Genetic relatedness of A. baumannii isolates was investigated by semi-automated repetitive element palindromic (rep)-PCR using the DiversiLab® strain typing platform (BioMérieux, Nürtingen, Germany) as previously described . Results were utilized with the DiversiLab® software using Pearson correlation to determine distance matrices and the unweighted pair group method with arithmetic averages to create dendrograms. MIC data were generated using the VITEK 2 system and AST-GN38 testing cards (BioMérieux).
Genome and plasmid sequencing and annotation
Whole-genome sequencing of A. baumannii strain IHIT7853 was performed on an Illumina MiSeq (MiSeq Reagent Kit v3, Illumina Inc.) resulting in 300 bp paired-end reads and an average coverage of 130×. De novo assembly after quality trimming of the reads was conducted using CLC Genomics Workbench v. 9 (CLC bio, Denmark) with standard parameters, scaffolding and exclusion of contigs smaller than 200 bp. The genome was annotated using the Rapid Annotation using Subsystem Technology (RAST) server .
Functional classification of the genes was conducted by BLASTP with the Clusters of Orthologous Groups of proteins (COG) database . Prediction of phage sequences and clustered regularly interspaced short palindromic repeats (CRISPRs) was performed with PHAST  and CRISPRfinder . Antimicrobial resistance genes and insertion sequences were identified using the CGE website  and ISfinder, respectively .
Strain IHIT7960 was isolated from a dog in the same clinic where IHIT7853 has been obtained, and proved to be a natural plasmid-free, isogenic variant of A. baumannii IHIT7853. IHIT7960 was whole genome sequenced and de novo assembled as mentioned before. Whole genome sequencing reads from the plasmid-containing strain IHIT7853 were mapped against the genome of IHIT7960 and all reads that could not be mapped, and therefore represent plasmid DNA, were de novo assembled as described above. Few reads that could not be mapped during de novo assembly but did not represent plasmid sequences were not used to generate the plasmid contig.
For comparative genomic analysis, genome sequences of representative A. baumannii strains were downloaded from the NCBI website: ATCC 17978 (CP012004), LAC-4 (CP007712), ABBL102 (LLHC00000000), TYTH-7 (AGSV00000000), GTC 03328 (BBNI00000000), RUH1486 (JZBU00000000), AB030 (CP009257), MDR-ZJ06 (CP001937), MDR-TJ (CP003500), NCGM 237 (AP013357), NIPH 1669 (APOQ00000000), AB307-0294 (NC_011595), strain A1 (CP010781), AYE (CU459141.1), AB0057 (NC_011586.1), TTU2014-131AME (LKJZ00000000), and FDAARGOS_123 (LORJ00000000). The source of the strains is given in Fig. 3. MLST types were determined following the Institute Pasteur  and Oxford  approach and using the CGE server . The determination of the maximum common genome (MCG) alignment was done comprising those genes present in all 18 downloaded genomes . For this purpose, we clustered the coding sequences based on the parameters sequence similarity (min. 70 %) and coverage (min. 90 %) and defined the genes that were present in each genome, thereby fulfilling the threshold parameters as MCG. This resulted in 2480 orthologous genes which we used for comparisons. Allelic variants of these genes from all genomes were then extracted by a BLAST-based approach, aligned individually for each gene and concatenated. This resulted in an alignment of 2.157 Mbp for the 18 A. baumannii strains. The alignment was used to generate a phylogenetic tree with RAxML 8.1  using a General Time Reversible model and gamma correction for among site rate variation.
Acinetobacter baumannii IHIT7853 that was obtained from a single colony was maintained at the Institute of Hygiene and Infectious Diseases, Giessen, Germany, and genomic DNA was extracted from a pure culture. The 16S rDNA from the draft genome was used to check for contamination. GyrB gene sequencing and VITEK 2 biochemical identification (BioMérieux, Nürtingen, Germany) confirmed that the strain IHIT7853 belonged to the species A. baumannii. Possible contamination with other genomes and misassemblies were checked by mapping the reads back to the contigs. The read mapping of the draft genome of IHIT7853 is in the range of expected size distribution and the coverage of the reads was consistent throughout the genome.
Results and discussion
General features of the A. baumannii IHIT7853 genome
Number of contigs
Total contig length (bp)
Fold coverage (x)
G + C content (%)
Number of protein coding genes
Number of predicted transfer RNAs
Number of predicted ribosomal RNAs
GenBank accession number
General features of the pOXA-23-IHIT7853 plasmid
Number of contigs
Total contig length (bp)
Fold coverage (x)
G + C content (%)
Number of protein coding genes
GenBank accession number
Five prophage regions have been identified in the genome of IHIT7853, of which 2 regions are intact and 3 regions are incomplete. Intact phages are (i) phi CTX, a P2-like cytotoxin-converting phage of Pseudomonas aeruginosa (Acc-No. NC_003278) of 34.1 kb in length and a G + C content of 38.72 % and (ii) Acinetobacter phage YMC/09/02/B1251_ABA_BP (NC_019541), which is 45.36 kb in length, reveals a G + C content of 39.05 % and has previously been demonstrated to cause lysis of an OXA-23-producing carbapenem-resistant A. baumannii isolate from a septic patient . One CRISPR candidate was detected consisting of 28 bp-repeat-areas and 54 spacers. Located downstream of the repeat and spacer region are the cas genes csy4—csy1, cas3, and cas1. Several insertion sequence (IS) elements, including ISAba1, ISAba12, IS15, IS17, and IS26 were identified using IS Finder.
The bla OXA-23 gene of A. baumannii IHIT7853 was localized on a 53.99 kb plasmid that also encoded aminoglycoside resistance genes strA and strB. Other resistance genes detected in the genome of IHIT7853 were aminoglycoside resistance genes aadA1, aph(3´) and aac(3)-Ia, β-lactamase gene bla OXA-69 (lacking an upstream insertion sequence), phenicol resistance gene catA1, and the genes sul1 and tet(A) coding for sulfonamide and tetracycline resistance, respectively. In agreement with these genetic features, high MICs were identified for imipenem (≥16 mg/L), piperacillin (≥16 mg/L), cefpirome (≥64 mg/L), gentamicin (≥16 mg/L), tetracycline (≥16 mg/L), and trimethoprim/sulfamethoxazole (≥32 mg/L). MICs to enrofloxacin (2 mg/L) and marbofloxacin (≥4 mg/L) are in correspondence with the finding of a single mutation in the gyrA sequence, resulting in an amino acid change from serine to leucine at position 83.
This is the first description of the genome and the OXA-23 plasmid sequence of a carbapenem-resistant A. baumannii from an animal. So far, whole genome studies of A. baumannii have nearly exclusively focused on comparing strains from human patients. Genome data of IHIT7853 revealed high relatedness of the cat strain to human clinical strains providing evidence for a possible transmission of these bacteria between humans and animals. Based on knowledge from human patients it should be considered that the gastrointestinal tract of animals might serve as a source of MDR A. baumannii probably leading to infections at other sites [2, 3]. Future studies should unveil epidemiologic links between human and animal strains and track the genome dynamics in MDR A. baumannii from different hosts as well as from colonization and infection sites.
CE conceived, organized and supervised the project. CE, SG and TS interpreted the results, and edited the manuscript. SS and PK characterized the strains and maintained them in pure cultures. UL and SG performed antimicrobial susceptibility testing and rep-PCR analysis. UL prepared the high-quality genomic DNA, arranged the acquisition of sequence data and did the PFGE analysis. TS and CE performed the sequence assembly, gene prediction, gene annotation, analyzed the genome information, and drafted the manuscript. All authors read and approved the final manuscript.
The authors are thankful to Petra Krienke and Inga Eichhorn for technical assistance during DNA sequencing.
The authors declare that they have no competing interests.
Availability of supporting data
The whole genome sequence of IHIT7853 and the sequence of pOXA-23-IHIT7853 have been deposited at GenBank under the accession number LWTH00000000 and KX118105, respectively.
Consent for publication
This study was financed by internal funding. PK was supported by grant from the Engemann Family Foundation.
- 5.Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, Harrison LH, Doi Y. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother. 2008;52(11):3837–43.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Coelho JM, Turton JF, Kaufmann ME, Glover J, Woodford N, Warner M, Palepou MF, Pike R, Pitt TL, Patel BC, et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England. J Clin Microbiol. 2006;44(10):3623–7.CrossRefPubMedPubMedCentralGoogle Scholar
- 16.The CGE (Center for Genomic Epidemiology) server. https://cge.cbs.dtu.dk/services/MLST/. Accessed 12 May 2016.
- 22.Jeon J, Kim JW, Yong D, Lee K, Chong Y. Complete genome sequence of the podoviral bacteriophage YMC/09/02/B1251 ABA BP, which causes the lysis of an OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolate from a septic patient. J Virol. 2012;86(22):12437–8.CrossRefPubMedPubMedCentralGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.